IsoRay Announces World's First Pediatric Cesium-131 Seeded Mesh Treatment for Metastatic Wilms Tumor
Cesium-131 Implants Used to Provide Needed Radiation to Treat This Aggressive Cancer
RICHLAND, WA--(Healthcare Sales & Marketing Network) - IsoRay Inc. (NYSE MKT: ISR) (http://www.isoray.com/), a medical technology company and innovator in seed brachyth... Devices, OncologyIsoRay, brachytherapy, Cesium-131, radiotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Brachytherapy | Cancer | Cancer & Oncology | Marketing | Pediatrics | Pharmaceuticals | Wilm's Tumor